| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 209.52% | HC Wainwright & Co. | → $26 | Reiterates | Buy → Buy |
| 09/21/2023 | 209.52% | HC Wainwright & Co. | $23 → $26 | Maintains | Buy |
| 08/17/2023 | 328.57% | Oppenheimer | $63 → $36 | Maintains | Outperform |
| 08/17/2023 | 173.81% | HC Wainwright & Co. | → $23 | Reiterates | Buy → Buy |
| 05/31/2023 | 650% | Oppenheimer | → $63 | Reiterates | Outperform → Outperform |
| 05/31/2023 | 173.81% | HC Wainwright & Co. | → $23 | Reiterates | Buy → Buy |
| 03/17/2023 | 173.81% | HC Wainwright & Co. | → $23 | Reiterates | → Buy |
| 01/04/2023 | 173.81% | HC Wainwright & Co. | $5.5 → $23 | Maintains | Buy |
| 12/30/2022 | 197.62% | Cowen & Co. | $6 → $25 | Maintains | Outperform |
| 12/22/2022 | 197.62% | Maxim Group | → $25 | Initiates Coverage On | → Buy |
| 12/21/2022 | 650% | Oppenheimer | $9 → $63 | Maintains | Outperform |
| 11/16/2022 | -34.52% | HC Wainwright & Co. | $6 → $5.5 | Maintains | Buy |
| 07/18/2022 | -16.67% | Oppenheimer | → $7 | Assumes | → Outperform |
| 05/18/2022 | -4.76% | Wells Fargo | $7 → $8 | Maintains | Overweight |
| 03/21/2022 | -16.67% | Aegis Capital | $9 → $7 | Maintains | Buy |
| 08/17/2021 | 7.14% | Aegis Capital | $10 → $9 | Maintains | Buy |
| 08/11/2021 | -22.62% | HC Wainwright & Co. | $7 → $6.5 | Maintains | Buy |
| 03/02/2021 | 19.05% | Aegis Capital | → $10 | Initiates Coverage On | → Buy |
| 09/23/2020 | -28.57% | BTIG | → $6 | Initiates Coverage On | → Buy |
| 08/05/2019 | -34.52% | HC Wainwright & Co. | → $5.5 | Initiates Coverage On | → Buy |
What is the target price for MediWound (MDWD)?
The latest price target for MediWound (NASDAQ: MDWD) was reported by HC Wainwright & Co. on November 22, 2023. The analyst firm set a price target for $26.00 expecting MDWD to rise to within 12 months (a possible 209.52% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MediWound (MDWD)?
The latest analyst rating for MediWound (NASDAQ: MDWD) was provided by HC Wainwright & Co., and MediWound reiterated their buy rating.
When is the next analyst rating going to be posted or updated for MediWound (MDWD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating MediWound (MDWD) correct?
While ratings are subjective and will change, the latest MediWound (MDWD) rating was a reiterated with a price target of $0.00 to $26.00. The current price MediWound (MDWD) is trading at is $8.40, which is within the analyst's predicted range.